← Open Payments lookup

EUGENE ROSENMAN: Open Payments

NPI 1659433787 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$394 in 15 payments from 6 companies in 2025. Trend: 2023 $133 · 2024 $308 · 2025 $394

Food & beverage: $394
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$104
E.R. Squibb & Sons, L.L.C.4$102
Teva Pharmaceuticals USA, Inc.2$77
Neurocrine BioSciences, Inc.3$75
Indivior Inc.1$23
Supernus Pharmaceuticals, Inc.1$14

Products named: REXULTI, COBENFY, AUSTEDO XR, INGREZZA, SUBLOCADE, Qelbree.

Industry payments across NV — which companies pay providers there.